Articles by Matthew Sample
The Supply Chain Has Modernized. Prescribing Information Should Too.
BMS’s Kevin Cook explains why digital capability is becoming a must-have for strategic CMO partners and why the next phase starts with the basics.
Is Pharma Moving Too Fast on AI Agents?
Zoomlogi’s Henry Ames says exception handling still hinges on experienced staff, and AI agents could gather and document details for their judgment calls.
Inside Cencora's Approach to AI-Driven Demand Sensing
At LogiPharma USA 2026, quality leaders explained why connected data, risk-based prioritization, and human accountability must come before AI in supply chain compliance.
How To Make Direct-To-Patient Models Work For All Stakeholders
Direct-to-patient (DTP) models are positioned as a way to simplify and improve the patient experience—but their success depends just as much on how well they integrate into the day-to-day realities of healthcare professionals (HCPs) and pharmacies. As manufacturers expand their use of DTP strategies, friction often emerges not at the patient level, but within the workflows of the stakeholders responsible for prescribing, dispensing, and supporting access.
Understanding the FDA's Exemption for DSCSA Compliance
On Oct. 9, 2024—49 days before the end of the one-year stabilization period under the Drug Supply Chain Security Act (DSCSA)—the FDA issued an exemption1 for eligible trading partners that will continue to delay enforcement regarding compliance with the law’s final enhanced drug distribution security requirements. The exemption duration varies by partner type: Manufacturers and Repackagers: Until May 27, 2025 Wholesale Distributors: Until Aug.
CytoDirect: A Nucleic Acid Nanodevice for Specific and Efficient Delivery of Functional Payloads to the Cytoplasm
Nanomedicine aims to utilize the chemical and physical properties of nanomaterials for the diagnosis and treatment of diseases at the molecular or nanoscale level. (1) However, the therapeutic potential of various drug modalities─including oligonucleotides like mRNAs and siRNA, proteins, plasmids, and antitumor drugs─has not been fully realized due to their poor cell membrane permeability, endo/lysosomal entrapment, enzymatic degradation, and rapid liver clearance.
CytoDirect: A Nucleic Acid Nanodevice for Specific and Efficient Delivery of Functional Payloads to the Cytoplasm
Download Hi-Res ImageDownload to MS-PowerPointCite This:J. Am. Chem. Soc. 2023, XXXX, XXX Terms & Conditions Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses).
Three Challenges for the Cosmopolitan Governance of Technoscience
Promising new solutions or risking unprecedented harms, science and its technological affordances are increasingly portrayed as matters of global concern, requiring in-kind responses. In a wide range of recent discourses and global initiatives, from the International Summits on Human Gene Editing to the Intergovernmental Panel on Climate Change, experts and policymakers routinely invoke cosmopolitan aims.
Prospects for a cosmopolitan right to scientific progress - Nature Physics
Declaring a cosmopolitan right to scientific progress risks perpetuating the inequities it aims to overcome. Instead, science ought to be reimagined in a way that directly addresses its links to nationalist projects and harmful capitalist practices.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Matthew
Contact Matthew, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack